Partenariat entre Pfizer et Avillion afin de co-développer BOSULIF® (bosutinib) comme traitement de première ligne en LMC.

Avillion Group Partners with Pfizer to Co-develop BOSULIF® (bosutinib) as First-Line Treatment for Patients with CML